🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 30% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 mL Serving Size
30 Servings
Fat/Fatty Acid Product Type
30% Evidence Coverage

Supplement Facts — Evidence Check

Calories
18 {Calories}
Total Fat
1.8 g (3% DV)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 236.6mg UL 3000mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 310mg UL 3000mg
Alpha-Linolenic Acid
125 mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 670mg UL 3000mg
Gamma-Linolenic Acid
12 mg
Linoleic Acid
40.6 mg
Oleic Acid
10.8 mg
Other Fatty Acids

Other Ingredients

Tropical Oils Natural Flavors Tocopherol Rosemary extract CoQ10

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Sugar Free

Product Information

📋 Directions for Use

DIRECTIONS: TAKE 2 mL DAILY.

🧪 Formulation Notes

No sugar. No alcohol. No artificial color. No artificial flavor.

Omega Fatty Acids DHA, EPA (3,3,9)

Additional Information

#197 I/8

SUPER CONCENTRATE

Ultra pure OMGA LQ essential fatty acids (Omega 3,6,9) promotes healthy heart, brain, and joints.

KEEP REFRIGERATED

MADE IN U.S.A.

Product Details

UPC / SKU 6 35585 01971 2
DSLD Entry Date 2013-06-25
Product Type Fat/Fatty Acid
Form Liquid
DSLD ID 22120
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →